
Mahmoud Fatahi Yar
Examiner (ID: 19180)
| Most Active Art Unit | 2609 |
| Art Unit(s) | 2609, 2604, 2629, 2774, 2674, 2899, 2606 |
| Total Applications | 600 |
| Issued Applications | 471 |
| Pending Applications | 2 |
| Abandoned Applications | 127 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10382160
[patent_doc_number] => 20150267167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'MULTIPOTENT ADULT STEM CELLS AND METHODS FOR ISOLATION'
[patent_app_type] => utility
[patent_app_number] => 14/733514
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 36040
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14733514
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/733514 | Pluripotent cells derived from bone marrow and methods for isolation | Jun 7, 2015 | Issued |
Array
(
[id] => 11668336
[patent_doc_number] => 20170157057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'GRAFT MATERIAL AND METHOD FOR PREPARING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/313020
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4395
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313020
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313020 | Method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3 | May 21, 2015 | Issued |
Array
(
[id] => 10671226
[patent_doc_number] => 20160017371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'STEM CELL GENE TARGETING'
[patent_app_type] => utility
[patent_app_number] => 14/717472
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10970
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14717472
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/717472 | Stem cell gene targeting | May 19, 2015 | Issued |
Array
(
[id] => 11528881
[patent_doc_number] => 20170088859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'ADENOASSOCIATED VIRUS VECTORS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/310524
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 15855
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310524
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310524 | Adenoassociated virus vectors for the treatment of lysosomal storage disorders | May 12, 2015 | Issued |
Array
(
[id] => 14419023
[patent_doc_number] => 10314295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Mouse model of hyperuricemia
[patent_app_type] => utility
[patent_app_number] => 15/308116
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 9238
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308116
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308116 | Mouse model of hyperuricemia | May 6, 2015 | Issued |
Array
(
[id] => 11298039
[patent_doc_number] => 09506034
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Method of enriching for pancreatic endoderm cells'
[patent_app_type] => utility
[patent_app_number] => 14/700608
[patent_app_country] => US
[patent_app_date] => 2015-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22873
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14700608
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/700608 | Method of enriching for pancreatic endoderm cells | Apr 29, 2015 | Issued |
Array
(
[id] => 10443253
[patent_doc_number] => 20150328265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'Method Of Using Mitotically Inactivated Stem Cells For Damaged Tissue Repair'
[patent_app_type] => utility
[patent_app_number] => 14/697281
[patent_app_country] => US
[patent_app_date] => 2015-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9018
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14697281
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/697281 | Method of using mitotically inactivated stem cells for damaged tissue repair | Apr 26, 2015 | Issued |
Array
(
[id] => 10657663
[patent_doc_number] => 20160003807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'TLR8 TRANSGENIC ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 14/694919
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17974
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694919
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/694919 | TLR8 TRANSGENIC ANIMALS | Apr 22, 2015 | Abandoned |
Array
(
[id] => 11409162
[patent_doc_number] => 09556454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'Generation of induced pluripotent stem (iPS) cells'
[patent_app_type] => utility
[patent_app_number] => 14/692250
[patent_app_country] => US
[patent_app_date] => 2015-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 13490
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14692250
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/692250 | Generation of induced pluripotent stem (iPS) cells | Apr 20, 2015 | Issued |
Array
(
[id] => 11542857
[patent_doc_number] => 20170096682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'AAV VECTORS FOR VASCULAR GENE THERAPY IN CORONARY HEART DISEASE AND PERIPHERAL ISCHAEMIA'
[patent_app_type] => utility
[patent_app_number] => 15/303823
[patent_app_country] => US
[patent_app_date] => 2015-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 10875
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303823
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/303823 | AAV VECTORS FOR VASCULAR GENE THERAPY IN CORONARY HEART DISEASE AND PERIPHERAL ISCHAEMIA | Apr 12, 2015 | Abandoned |
Array
(
[id] => 12002244
[patent_doc_number] => 20170306400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'BIOMARKER FOR DIAGNOSIS OF AGING OR AMYOTROPHIA'
[patent_app_type] => utility
[patent_app_number] => 15/301212
[patent_app_country] => US
[patent_app_date] => 2015-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11563
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301212
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301212 | BIOMARKER FOR DIAGNOSIS OF AGING OR AMYOTROPHIA | Apr 2, 2015 | Abandoned |
Array
(
[id] => 16547950
[patent_doc_number] => 10881085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Non-human animals that make single domain binding proteins
[patent_app_type] => utility
[patent_app_number] => 14/664765
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 24884
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664765
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664765 | Non-human animals that make single domain binding proteins | Mar 19, 2015 | Issued |
Array
(
[id] => 11703620
[patent_doc_number] => 20170172118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'ESSENTIAL FATTY ACID-PRODUCING NONHUMAN TRANSGENIC ANIMALS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/127295
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 40444
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15127295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/127295 | Transgene construct encoding delta 12 fatty acid | Mar 19, 2015 | Issued |
Array
(
[id] => 10306696
[patent_doc_number] => 20150191698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'ADIPOSE-DERIVED STEM CELLS AND LATTICES'
[patent_app_type] => utility
[patent_app_number] => 14/659308
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9755
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14659308
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/659308 | ADIPOSE-DERIVED STEM CELLS AND LATTICES | Mar 15, 2015 | Abandoned |
Array
(
[id] => 10288334
[patent_doc_number] => 20150173332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Human Lambda Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/638429
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26447
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14638429
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/638429 | Method of making antibodies using a human lambda light chain mouse | Mar 3, 2015 | Issued |
Array
(
[id] => 10291003
[patent_doc_number] => 20150176002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Human Lambda Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/638424
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26448
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14638424
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/638424 | Method of cloning a lambda light chain variable domain using a human lambda light chain mouse | Mar 3, 2015 | Issued |
Array
(
[id] => 10288333
[patent_doc_number] => 20150173331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Human Lambda Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/636784
[patent_app_country] => US
[patent_app_date] => 2015-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26437
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14636784
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/636784 | Method of making antibodies using a human lambda light chain mouse | Mar 2, 2015 | Issued |
Array
(
[id] => 10333508
[patent_doc_number] => 20150218512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'MESODERM AND DEFINITIVE ENDODERM CELL POPULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/632600
[patent_app_country] => US
[patent_app_date] => 2015-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 14011
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14632600
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/632600 | MESODERM AND DEFINITIVE ENDODERM CELL POPULATIONS | Feb 25, 2015 | Abandoned |
Array
(
[id] => 10355258
[patent_doc_number] => 20150240263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION'
[patent_app_type] => utility
[patent_app_number] => 14/630128
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23240
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/630128 | Method of treating factor IX deficiency using nuclease-mediated targeted integration | Feb 23, 2015 | Issued |
Array
(
[id] => 10265228
[patent_doc_number] => 20150150225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'TRANSGENIC MOUSE EXPRESSING HUMAN ISOGLUTAMINYL CYCLOTRANSFERASE'
[patent_app_type] => utility
[patent_app_number] => 14/619220
[patent_app_country] => US
[patent_app_date] => 2015-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19837
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14619220
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/619220 | TRANSGENIC MOUSE EXPRESSING HUMAN ISOGLUTAMINYL CYCLOTRANSFERASE | Feb 10, 2015 |